Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services entities : Centogene n.v. save search
CENTOGENE Receives Nasdaq Non-Compliance Notice
Published: 2024-04-02 (Crawled : 21:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -0.5%
H: 5.97%
C: 3.01%
nasdaq
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
TAK | News | $13.35 -0.08% 230K
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 1.43%
H: 1.41%
C: -1.41%
partnership genetic takeda disorders
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
Published: 2024-02-29 (Crawled : 22:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -10.49%
H: 13.83%
C: 11.11%
research
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
Published: 2024-02-28 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 0.55%
H: 2.04%
C: 0.61%
nasdaq
Clinical Biomarkers Market Analysis and Forecast, 2023-2033 - Cancer Biomarkers to Witness the Highest Growth between 2023 and 2033
Published: 2024-02-13 (Crawled : 03:00) - prnewswire.com
TMO | News | $572.645 4.43% 800K
|
Health Technology
|
| O: -0.99%
H: 0.88%
C: -0.52%
DGX | News | $136.42 4.87% 530K
|
Health Services
|
| O: 0.01%
H: 0.55%
C: -1.66%
QGEN | $41.58 0.87% 150K
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
BIO | $290.54 3.72% 59K
|
Health Technology
|
| O: -1.32%
H: 0.37%
C: -1.83%
BDX | $234.72 0.36% 150K
|
Health Technology
|
| O: 0.04%
H: 0.72%
C: -1.81%
A | $137.89 3.02% 420K
|
Health Technology
|
| O: -2.03%
H: 1.0%
C: -0.44%
ABT | News | $107.565 0.46% 610K
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: 0.0%
QGEN | $41.58 0.87% 150K
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
MYGN | $18.725 1.27% 82K
|
Health Technology
|
| O: -3.99%
H: 1.49%
C: -3.71%
ILMN | $124.595 3.61% 400K
|
Health Technology
|
| O: -2.48%
H: 1.08%
C: -2.01%
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 2.59%
H: 0.0%
C: -11.11%
cancer biomarkers growth market
Europe Next Generation Sequencing (NGS) Market Report 2023-2033: Evolving Regulatory Landscape for Clinical NGS and Growing Number of Gene Mutations across Various Diseases Present Opportunities
Published: 2024-02-06 (Crawled : 20:00) - prnewswire.com
TMO | News | $572.645 4.43% 800K
|
Health Technology
|
| O: 0.31%
H: 0.71%
C: -1.72%
QGEN | $41.58 0.87% 150K
|
Health Technology
|
| O: -1.25%
H: 0.07%
C: -1.63%
QGEN | $41.58 0.87% 150K
|
Health Technology
|
| O: -1.25%
H: 0.07%
C: -1.63%
PACB | $1.6 2.56% 1.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -4.1%
ILMN | $124.595 3.61% 400K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -1.48%
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -3.4%
H: 9.54%
C: 9.43%
europe report growing market
Carrier Screening Market Worth $5.4 Billion | MarketsandMarkets™
Published: 2024-01-31 (Crawled : 15:30) - prnewswire.com
TMO | News | $572.645 4.43% 800K
|
Health Technology
|
| O: -0.67%
H: 0.48%
C: -4.32%
DGX | News | $136.42 4.87% 530K
|
Health Services
|
| O: 0.46%
H: 0.41%
C: -0.76%
LH M | $206.935 1.9% 140K
|
Health Services
|
| O: 0.53%
H: 0.0%
C: -2.31%
NVTA | News | $0.019 0.0% 22M
|
Health Services
|
| O: -0.2%
H: 2.4%
C: -3.7%
OPK | $1.245 1.22% 310K
|
Health Technology
|
| O: 0.0%
H: 4.95%
C: 0.99%
NTRA | News S | $92.37 4.24% 150K
|
Health Services
|
| O: -0.76%
H: 2.2%
C: 0.67%
ILMN | $124.595 3.61% 400K
|
Health Technology
|
| O: -0.49%
H: 1.17%
C: -2.37%
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -0.86%
H: 0.0%
C: -0.43%
market
Europe Next-Generation Breast Cancer Diagnostic and Screening Market Analysis and Forecast 2023-2032: The Future is Bright as Market Set to Register a CAGR of 13.20%
Published: 2024-01-26 (Crawled : 18:00) - prnewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -1.7%
H: 4.34%
C: -0.88%
europe diagnostic breast cancer set market
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
Published: 2024-01-25 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -2.5%
H: 5.13%
C: 0.0%
rare disease research collaboration
CENTOGENE Receives French Research Tax Credit Accreditation
Published: 2024-01-24 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -2.4%
H: 0.0%
C: -1.64%
research
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
Published: 2024-01-23 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 0.0%
H: 0.0%
C: 0.0%
disease genetic risk research parkinson’s
CENTOGENE Announces Preliminary Full Year 2023 Revenue
Published: 2024-01-18 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -2.42%
H: 3.31%
C: 3.31%
year revenue
CENTOGENE Announces Voting Results of Extraordinary General Meeting
Published: 2023-12-19 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -1.72%
H: 6.14%
C: 6.14%
meeting results
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
Published: 2023-12-13 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -4.72%
H: 5.79%
C: 3.31%
genetic dementia milestone
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 3.17%
H: 3.46%
C: 0.77%
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
Published: 2023-11-14 (Crawled : 13:30) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 10.25%
H: 0.78%
C: -0.78%
disease global
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
Published: 2023-10-10 (Crawled : 11:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -0.68%
H: 1.66%
C: 1.66%
diagnostic offering
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-11 (Crawled : 12:30) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: -4.55%
H: 6.67%
C: 0.95%
conference global
CENTOGENE Reports First Half 2023 Financial Results
Published: 2023-09-07 (Crawled : 21:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 0.0%
H: 3.77%
C: 3.77%
financial results
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
Published: 2023-09-01 (Crawled : 12:00) - globenewswire.com
CNTG | $0.4701 14K
|
Commercial Services
|
| O: 0.84%
H: 0.0%
C: -5.83%
disease biomarker publication
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.